Ypsomed Holding Stock
Ypsomed Holding AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- Switzerland
- CEO
- Simon Michel
- Employees
- 2,025
- Market cap
- CHF5 B
- IPO
- 22/09/2004
Ypsomed Holding AG is a healthcare company that develops, manufactures, and sells injection and infusion systems designed for safe and simple self-medication. Founded in 1984, the company is headquartered in Burgdorf, Switzerland. The business operates through three segments: the Ypsomed Delivery Systems segment, the…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Ypsomed Holding stock: price history
1D
-0.2%
1W
+4.3%
1M
+7.6%
6M
+27.0%
YTD
+15.1%
1Y
+19.9%
2Y
-4.9%
5Y
+147.9%
10Y
+96.3%
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~62% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ypsomed Holding stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
2 more assignments (Enabler/Second row) Pro-only.
Ypsomed Holding AG is a medical technology company specializing in the development and manufacturing of injection and infusion systems for self-medication. The offering is divided into two main segments: the YDS brand encompasses various injection systems such as pen injectors and wearables, while in the Diabetes Care area, the mylife brand trades insulin pumps as well as consumables such as cannulas and accessories. In addition to product distribution, the company offers services in precision manufacturing and as a contract manufacturer. Distribution takes place globally through pharmaceutical companies as well as its own distribution networks.
- Revenue model
- Hardware sales
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- None
- Moat type
- None
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Ypsomed Holding
Ypsomed Holding stock metrics
P/E
23.15
P/B
6.84
EV/EBITDA
15.22
RETURN ON EQUITY
11.1%
NET MARGIN
22.5%
DEBT/EQUITY
0.35
DIVIDEND YIELD
1.2%
AS OF
31/03/2026
Free float & liquidity
FREE FLOAT
26.7%
FLOAT SHARES
3,508,659
AVG. DAILY VOLUME (30D)
16,548
Dividends
Comparable stocks
Frequently asked questions about Ypsomed Holding stock
What does Ypsomed Holding do?
Ypsomed Holding AG is a company in the Healthcare sector, Medical - Specialties industry, headquartered in Switzerland.
The CEO is Simon Michel, the company employs around 2,025 people.
The IPO was on 22/09/2004; the stock trades on SIX under the ticker YPSN.SW.
When does Ypsomed Holding report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 62% stronger than usual.
Does Ypsomed Holding pay a dividend?
Yes. The last dividend was CHF 4.40 per share, ex-date 03/07/2026, paid on 07/07/2026.
The dividend yield is 1.2% (as of 31/03/2026).
Which stocks are comparable to Ypsomed Holding?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Roche Holding, BeOne Medicines and Sandoz Group.
How can I get Ypsomed Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Ypsomed Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.